MDxHealth is trading 5.4% up at $0.75 after an apparent rebound, with no confirmed fundamental catalyst identified.

  • It closed at $0.71 on September 8, 2026.
  • The regular session fell 4.66% amid healthcare-sector weakness.
  • No clear company-specific announcement, earnings release, or late-breaking catalyst was identified for September 8; latest company press coverage was its August 13 second-quarter report, and confidence is low.